| calcium channel, voltage-dependent, beta 1 subunit |
SAQUINAVIR |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
SAQUINAVIR |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
SAQUINAVIR |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SAQUINAVIR |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
NIMODIPINE |
Glucocorticoid |
49% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
OLANZAPINE |
Serotonin 5-HT1A |
49% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
RESERPINE |
Melanocortin MC3 |
49% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
RESERPINE |
Melanocortin MC3 |
49% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
ONDANSETRON |
Serotonin Transporter |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
ORPHENADRINE |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
ORPHENADRINE |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
OXICONAZOLE |
Sigma2 |
49% |
NoneNone |
NoneNone |
View
|
| adenosine A1 receptor |
LACIDIPINE |
Adenosine A1 |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
BROMFENAC |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
BROMFENAC |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
BROMFENAC |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
BROMFENAC |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
CETYLPYRIDINIUM BROMIDE |
Sigma1 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
RALOXIFENE |
Phosphodiesterase PDE3 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
RALOXIFENE |
Phosphodiesterase PDE3 |
49% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
PHENTOLAMINE |
Opiate delta |
49% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
RALOXIFENE |
Protein Tyrosine Kinase, HER2 Receptor |
49% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
RALOXIFENE |
Protein Tyrosine Kinase, HER2 Receptor |
49% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
ASTEMIZOLE |
Cannabinoid CB1 |
49% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
BAY 11-7085 |
Chemokine CCR5 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
BAY 11-7085 |
Adrenergic alpha2A |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CYPROHEPTADINE |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
GW-1929 |
Muscarinic M5 |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DISULFIRAM |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
ECONAZOLE |
ATPase, Na+/K+ |
49% |
NoneNone |
NoneNone |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 5 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 3 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PAROXETINE |
Potassium Channel HERG |
49% |
10.4293uM |
8.5445uM |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
HEXACHLOROPHENE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
49% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
HEXACHLOROPHENE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
49% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3, catalytic subunit, beta isoform |
HEXACHLOROPHENE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLOPIDOGREL |
Calcium Channel Type L, Phenylalkylamine |
49% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DIPHENHYDRAMINE |
Serotonin Transporter |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
DISULFIRAM |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
DISULFIRAM |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
CYCLOSPORIN A |
Adenosine Transporter |
49% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
CYCLOSPORIN A |
Adenosine Transporter |
49% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
CYCLOSPORIN A |
Adenosine Transporter |
49% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
CYCLOSPORIN A |
Adenosine Transporter |
49% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
CYCLOSPORIN A |
Adenosine Transporter |
49% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
RIFAMPIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
49% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
RIFAMPIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
49% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
RIFAMPIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
49% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
PACLITAXEL |
Testosterone |
49% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
AMLODIPINE |
Muscarinic M5 |
49% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
AMOXAPINE |
Dopamine D4.2 |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
AMIODARONE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
AMIODARONE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
AMIODARONE |
Cannabinoid CB1 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
BETAHISTINE |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
BETAHISTINE |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
TAMOXIFEN |
Phosphodiesterase PDE3 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
TAMOXIFEN |
Phosphodiesterase PDE3 |
49% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
NIFEDIPINE |
Glucocorticoid |
49% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Sigma2 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
ERGONOVINE |
Adrenergic alpha1D |
49% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
CLEMASTINE |
Protein Tyrosine Kinase, EGF Receptor |
49% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
CLOMIPRAMINE |
Dopamine D4.2 |
49% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
BENZOTHIAZYL DISULFIDE |
Cyclooxygenase COX-1 |
49% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BENZOTHIAZYL DISULFIDE |
Cyclooxygenase COX-1 |
49% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
BENZOTHIAZYL DISULFIDE |
Chemokine CCR4 |
49% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
BENZOTHIAZYL DISULFIDE |
Protein Tyrosine Kinase, Fyn |
49% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
FLUOCINONIDE |
CYP450-1A2 Inhibition |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
DIAZEPAM |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
DIAZEPAM |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4D |
DIAZEPAM |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
DIAZEPAM |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
MC 288769 |
Testosterone |
49% |
NoneNone |
NoneNone |
View
|
| cathepsin G |
MEFENAMIC ACID |
Protease, Cathepsin G |
49% |
NoneNone |
NoneNone |
View
|
| mast cell protease 9 |
MEFENAMIC ACID |
Protease, Cathepsin G |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
FLURBIPROFEN |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
FLURBIPROFEN |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
FLURBIPROFEN |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
FLURBIPROFEN |
Aldose Reductase |
49% |
NoneNone |
NoneNone |
View
|
| dopamine receptor 2 |
TRAZODONE |
Dopamine D2L |
49% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
HALOPERIDOL |
Melanocortin MC5 |
49% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
LABETALOL |
CYP450-2C19 Inhibition |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
GRISEOFULVIN |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
GRISEOFULVIN |
Imidazoline I2, Central |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
4-NONYLPHENOL |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
4-NONYLPHENOL |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
BROMOCRIPTINE |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
BROMOCRIPTINE |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4D |
BROMOCRIPTINE |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
BROMOCRIPTINE |
Phosphodiesterase PDE4 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
VERAPAMIL |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
VERAPAMIL |
Adrenergic alpha2C |
49% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
VERAPAMIL |
Serotonin 5-HT6 |
49% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D3 |
1-NAPHTHYL ISOTHIOCYANATE |
Dopamine D3 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
RWJ-68354 |
Adrenergic beta3 |
49% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
ITRACONAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
49% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
ITRACONAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
49% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
PROPRANOLOL |
Serotonin 5-HT1B |
49% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
TROPISETRON |
Muscarinic M4 |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
D-TUBOCURARINE CHLORIDE |
Adrenergic alpha1A |
49% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
D-TUBOCURARINE CHLORIDE |
Histamine H2 |
49% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
NORGESTREL |
Estrogen ERalpha |
49% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
NORGESTREL |
Estrogen ERalpha |
49% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
SAQUINAVIR |
Calcium Channel Type L, Dihydropyridine |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
ECONAZOLE |
GABAA, Chloride Channel, TBOB |
49% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
MICONAZOLE |
Protein Tyrosine Kinase, Lck |
49% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
KETOCONAZOLE |
Adenosine A3 |
49% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
KETOCONAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
49% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
KETOCONAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
49% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
DEXCHLORPHENIRAMINE |
Adrenergic alpha1A |
49% |
NoneNone |
NoneNone |
View
|
| mu-opioid receptor MOR |
FENOFIBRATE |
Opiate mu |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
FENOFIBRATE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
FENOFIBRATE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
CIGLITAZONE |
Serotonin 5-HT2A |
49% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
DEXCHLORPHENIRAMINE |
Serotonin 5-HT6 |
49% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
SULCONAZOLE |
Testosterone |
49% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
SULCONAZOLE |
Protein Tyrosine Kinase, EGF Receptor |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
BECLOMETHASONE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
BECLOMETHASONE |
Progesterone |
49% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
DANAZOL |
Opiate delta |
49% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
DIETHYLSTILBESTROL |
Protein Tyrosine Kinase, EGF Receptor |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
PHENOTHIAZINE |
Sodium Channel, Site 2 |
49% |
NoneNone |
NoneNone |
View
|